These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. Or YS; Clark RF; Wang S; Chu DT; Nilius AM; Flamm RK; Mitten M; Ewing P; Alder J; Ma Z J Med Chem; 2000 Mar; 43(6):1045-9. PubMed ID: 10737737 [No Abstract] [Full Text] [Related]
3. Synthesis and structure-activity relations in the class of 2-(pyridyl)penems. Bedeschi A; Visentin G; Perrone E; Giudici F; Zarini F; Franceschi G; Meinardi G; Castellani P; Jabes D; Rossi R J Antibiot (Tokyo); 1990 Mar; 43(3):306-13. PubMed ID: 2182592 [TBL] [Abstract][Full Text] [Related]
4. Studies on beta-lactam antibiotics. III. Syntheses and antibacterial activities of new 3-(1,3-dithiolan-2-yl)cephalosporins, YM-22508, YM-16457 and their prodrug-type esters. Nagano N; Satoh M; Hara R J Antibiot (Tokyo); 1991 Apr; 44(4):422-8. PubMed ID: 2032951 [TBL] [Abstract][Full Text] [Related]
5. [Cephalexin: microbiological activity in vitro and in vivo]. Muggleton PW; Renzini G; Ravagnan G; Orsolini P Antibiotica; 1969 Jun; 7(2):93-128. PubMed ID: 5399239 [No Abstract] [Full Text] [Related]
10. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. Tsuchiya K; Kondo M; Oishi T; Yamazaki I J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300 [No Abstract] [Full Text] [Related]
11. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity. Kondo M; Oishi T; Ishifuji K; Tsuchiya K J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049 [No Abstract] [Full Text] [Related]
12. The antibacterial activity of a new 3-azinomethyl-rifamycin. Strippoli V; Bruzzese T; Galli R; Simonetti N; Tronci N Farmaco Sci; 1988; 43(7-8):619-25. PubMed ID: 3147199 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of new 9-N-alkyl derivatives of 9(S)-erythromycylamine. Kirst HA; Wind JA; Leeds JP; Willard KE; Debono M; Bonjouklian R; Greene JM; Sullivan KA; Paschal JW; Deeter JB J Med Chem; 1990 Nov; 33(11):3086-94. PubMed ID: 2231610 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms]. Giunchi G Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414 [No Abstract] [Full Text] [Related]
15. The in vitro profile of selected 14-membered azalides. Jones AB; Herbert CM J Antibiot (Tokyo); 1992 Nov; 45(11):1785-91. PubMed ID: 1334956 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives. Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity]. Shorin VA; Pevzner NS Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685 [No Abstract] [Full Text] [Related]
18. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance. Goto S; Kuwahara S; Okubo N; Zenyoji H J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887 [No Abstract] [Full Text] [Related]
19. Current trends in antimicrobial therapy of infective endocarditis. Brown JW; McKnight GT J La State Med Soc; 1980 Apr; 132(4):58-62. PubMed ID: 6989939 [No Abstract] [Full Text] [Related]
20. [The antimicrobial activities of maidimeisu (author's transl)]. Want TL; Wang CD; Yan GH Yao Xue Xue Bao; 1980 Apr; 15(4):223-7. PubMed ID: 7457139 [No Abstract] [Full Text] [Related] [Next] [New Search]